Gabapentin Capsule
Product Images NDC 42582-116

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42582-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bi-coastal Pharma International Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (Image 04)

Cockcroft And Gault Equation (Image 04)
This appears to be a formula for calculating creatinine clearance (CLCr) using the patient's age and weight. However, some of the characters in the formula are not readable due to errors in the . Without further context, it is not clear what T3y and the unit ugdl represent. The formula also notes that female patients have a different factor (85) than male patients for calculating CLCr.*
FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Image 06)

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Image 07)

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Image 08)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjuctive Therapy Studies In Patients Greater Than Or Equal To 12 Years Of Age With Partial Seizures (Image 09)

FDA Label Image

Image Description (Label 100mg)

Image Description (Label 100mg)
This is a description of Gabapentin Capsules, USP distributed by Bi-Coastal Pharma International LLC. Each capsule contains 100 mg of Gabapentin, USP. The pharmacist is advised to dispense the medication guide separately to each patient. The prescription should be stored between 20-25°C (68-77°F) with excursions permitted between 15°-30°C (59°-86°F). Dispense in a well-closed container as defined in the USP. The package insert should be reviewed for full prescribing information. It was manufactured in Goa, India by Marksans Pharma Ltd. The lot number and expiration date are not available.*
FDA Label Image

Image Description (Label 300mg)

Image Description (Label 300mg)
NDC 42582-115-10 is a medication called Gabapentin manufactured by Marksans Pharma in India and distributed by Bi-Coastal Pharma International LLC . It is available in the form of capsules, USP containing 300 mg Gabapentin in each capsule. Dispensing of this medication must be accompanied by a medication guide provided to each patient. For dosage and use, the package insert should be thoroughly read. It should be stored at 20° to 25°C (68° to 77°F) with excursions allowed between 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature]. This medication should be dispensed in a well-closed container as defined in the USP. The lot number and expiry date are also provided.*
FDA Label Image

Image Description (Label 400mg)

Image Description (Label 400mg)
This is a description of Gabapentin Capsules, USP medication manufactured by Marksans Pharma Ltd. and distributed by Bi-Coastal Pharma International LLC. The medication comes in the form of 100 capsules, each containing 400mg of Gabapentin, USP. It is a prescription-only medication and comes with a Medication Guide. The dosage and usage guidelines are provided in the package insert. The medication should be stored at a temperature range of 20° to 25°C (68° to 77°F), with permitted excursions between 15° - 30°C (59° - 86°F). It should be dispensed in well-closed containers and has a unique LOT# and EXP. DATE.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.